Insulet PODD
NASDAQ PODD
$134.60 -3.32 (-2.41%)
As of: Sep 10, 2026 · 2:10 PM EDT

Insulet (PODD) Other Non Operating Income (2011 - 2026)

Insulet's (PODD) quarterly Other Non Operating Income came in at -$1.1 million in Q2 2026, up 98.7% on a YoY basis from -$553607.6 in Q2 2025, and down 257.14% quarter-over-quarter from $700000.0 in Q1 2026.

Analysis

Insulet (PODD) Other Non Operating Income (2011 - 2026) Analysis & Trends

Insulet (PODD) has reported Other Non Operating Income for 16 consecutive years, with -$1.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non Operating Income rose 98.7% year-over-year to -$1.1 million; the trailing twelve-month figure through Jun 2026 stood at $11.7 million (up 109.22% YoY), and the FY2025 full-year result was -$123.9 million, down 2152.73% from the prior year.
  • Other Non Operating Income declined to -$1.1 million in Q2 2026 per PODD's latest filing, from $700000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $12.1 million in Q3 2025 and bottomed at -$84.4 million in Q2 2025.
  • Historically, Other Non Operating Income has averaged -$6.9 million across 5 years, with a median of -$200000.0 in 2023.
  • The widest YoY moves for Other Non Operating Income: up 455.88% in 2025, down 5542.86% in 2025.
  • Over 5 years, Other Non Operating Income stood at $1.5 million in 2022, then gained by 26.67% to $1.9 million in 2023, then plunged by 78.95% to $400000.0 in 2024, then surged by 2925.0% to $12.1 million in 2025, then slumped by 109.09% to -$1.1 million in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered -$1.1 million, $700000.0, and $12.1 million for Q2 2026, Q1 2026, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 180.69 Bn 175.09 Bn 7.27 Bn
2 Intuitive Surgical 127.23 Bn 122.02 Bn 1.96 Bn
3 Medtronic 116.90 Bn 108.08 Bn 6.34 Bn
4 Stryker 103.91 Bn 100.43 Bn 4.50 Bn
5 Boston Scientific 63.54 Bn 63.00 Bn 3.85 Bn
6 Edwards Lifesciences 49.74 Bn 45.49 Bn 1.35 Bn
7 Alcon 32.96 Bn 31.51 Bn 1.68 Bn
8 Dexcom 32.02 Bn 30.07 Bn 830.00 Mn
9 Steris 20.70 Bn 20.21 Bn 684.20 Mn
10 Insulet 9.33 Bn 8.79 Bn 562.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.10 Mn
Mar 31, 2026 700,000.00
Sep 30, 2025 12.10 Mn
Jun 30, 2025 -84.40 Mn
Mar 31, 2025 -39.50 Mn
Dec 31, 2024 400,000.00
Sep 30, 2024 -3.40 Mn
Jun 30, 2024 -1.80 Mn
Mar 31, 2024 -700,000.00
Dec 31, 2023 1.90 Mn
Sep 30, 2023 700,000.00
Jun 30, 2023 -200,000.00
Mar 31, 2023 -200,000.00
Dec 31, 2022 1.50 Mn
Sep 30, 2022 -1.80 Mn
Jun 30, 2022 -1.10 Mn
Mar 31, 2022 300,000.00
Dec 31, 2021 -800,000.00
Sep 30, 2021 -1.50 Mn
Jun 30, 2021 -40.10 Mn